PMID: 8606058Jan 1, 1996Paper

A peptide encoded by the human MAGE3 gene and presented by HLA-B44 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE3

Immunogenetics
J HermanP G Coulie

Abstract

The human MAGE3 gene is expressed in a significant proportion of tumors of various histological types, but is silent in normal adult tissues other than testis and placenta. Antigens encoded by MAGE3 may therefore be useful targets for specific antitumor immunization. Two antigenic peptides encoded by the MAGE3 gene have been reported previously. One is presented to cytolytic T lymphocytes (CTL) by HLA-A1, the other by HLA-A2 molecules. Here we show that MAGE3 also codes for a peptide that is presented to CTL by HLA-B44. MAGE3 peptides containing the HLA-B44 peptide binding motif were synthesized. Peptide MEVDPIGHLY, which showed the strongest binding to HLA-B44, was used to stimulate blood T lymphocytes from normal HLA-B44 donors. CTL clones were obtained that recognized not only HLA-B44 cells sensitized with the peptide, but also HLA-B44 tumor cell lines expressing MAGE3. The proportion of metastatic melanomas expressing the MAGE3/HLA-B44 antigen should amount to approximately 17% in the Caucasian population, since 24% of individuals carry the HLA-B44 allele and 76% of these tumors express MAGE3.

References

Nov 11, 1992·International Journal of Cancer. Journal International Du Cancer·F BrasseurT Boon
Mar 1, 1991·Tissue Antigens·K FleischhauerS Y Yang
Dec 27, 1990·The New England Journal of Medicine·K FleischhauerS Y Yang
May 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·B Seed, A Aruffo
Mar 16, 1988·Journal of Immunological Methods·S Mikamo
Mar 15, 1994·Proceedings of the National Academy of Sciences of the United States of America·E CelisH M Serra
Jan 1, 1994·Cold Spring Harbor Symposia on Quantitative Biology·T BoonO De Backer
Nov 3, 1995·International Journal of Cancer. Journal International Du Cancer·F BrasseurY Humblet
Jun 22, 1995·International Journal of Cancer. Journal International Du Cancer·V RussoC Bordignon
Aug 15, 1995·Proceedings of the National Academy of Sciences of the United States of America·P G CoulieT Boon
Feb 20, 1995·International Journal of Cancer. Journal International Du Cancer·J J PatardD Chopin
Nov 1, 1993·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·H KitaM Imawari
Jan 1, 1995·Immunogenetics·Z YaoE D Albert
May 23, 1995·Proceedings of the National Academy of Sciences of the United States of America·F MuscatelliA P Monaco
Jul 1, 1994·The Journal of Experimental Medicine·N RomaniG Schuler
Jan 1, 1994·Annual Review of Immunology·T BoonA Van Pel
Jan 1, 1994·Immunogenetics·Z YaoE D Albert
Mar 15, 1994·International Journal of Cancer. Journal International Du Cancer·P WeynantsT Boon

❮ Previous
Next ❯

Citations

Nov 27, 1996·International Journal of Cancer. Journal International Du Cancer·K FleischhauerC Traversari
Jul 29, 1998·International Journal of Cancer. Journal International Du Cancer·P ChauxP van der Bruggen
Jun 8, 2000·International Journal of Cancer. Journal International Du Cancer·C LandryD Godelaine
Oct 30, 1999·European Journal of Immunology·M T DuffourP van der Bruggen
Jan 1, 1996·Springer Seminars in Immunopathology·P Romero
Jan 1, 1997·Immunologic Research·Y Kawakami, S A Rosenberg
May 13, 2008·Pathology Oncology Research : POR·T Schweighoffer
Aug 17, 2004·Cancer Immunology, Immunotherapy : CII·Luisa NovellinoGiorgio Parmiani
Jan 1, 2005·Cancer Immunology, Immunotherapy : CII·Tobias KrügerStefan Stevanović
Sep 28, 2005·Cancer Immunology, Immunotherapy : CII·Zhaojun SunPierre van der Bruggen
Nov 11, 2010·Journal of Huazhong University of Science and Technology. Medical Sciences = Hua Zhong Ke Ji Da Xue Xue Bao. Yi Xue Ying De Wen Ban = Huazhong Keji Daxue Xuebao. Yixue Yingdewen Ban·Haojun ShiXiaoling Lu
Oct 3, 2003·Human Immunology·Teresa CabreraFederico Garrido
Nov 22, 1997·Current Opinion in Immunology·B J Van den Eynde, P van der Bruggen
Oct 13, 2010·Proceedings of the National Academy of Sciences of the United States of America·Benoît GuillaumeBenoît J Van den Eynde
Oct 12, 2000·Proceedings of the National Academy of Sciences of the United States of America·E JägerA Knuth
Aug 15, 1995·Proceedings of the National Academy of Sciences of the United States of America·P G CoulieT Boon
Jan 21, 1997·Proceedings of the National Academy of Sciences of the United States of America·G Stuhler, S F Schlossman
Sep 27, 2000·Proceedings of the National Academy of Sciences of the United States of America·S GnjaticL J Old
Mar 1, 1996·The Journal of Experimental Medicine·T Boon, P van der Bruggen
Mar 2, 1999·The Journal of Experimental Medicine·P ChauxP van der Bruggen
May 29, 2003·The Journal of Experimental Medicine·Yoshiki AkatsukaToshitada Takahashi
Aug 27, 2003·The Journal of Experimental Medicine·Whitney A MacdonaldJames McCluskey
Aug 1, 1996·Annals of Surgery·M MoriT Akiyoshi
Apr 6, 2000·Current Opinion in Oncology·L H BrinckerhoffC L Slingluff
Oct 1, 1995·Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy·M WangN P Restifo
Sep 18, 1998·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·A F KirkinJ Zeuthen
Mar 10, 2011·Cellular and Molecular Life Sciences : CMLS·Nathalie Vigneron, Benoît J Van den Eynde
Dec 8, 2006·Expert Opinion on Biological Therapy·J Nemunaitis, J Nemunaitis
Mar 21, 2002·Cancer Investigation·Alexei F KirkinJesper Zeuthen
Nov 24, 1999·Immunological Reviews·R F Wang, S A Rosenberg
Dec 24, 2009·Head & Neck·Marija Pastorcic-GrgicMarko Grgic
Dec 31, 2011·Current Opinion in Immunology·Nathalie Vigneron, Benoît J Van den Eynde

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.